| #390 |
William Todd Rogers |
Arkema |
1 |
| #390 |
Judy A. Muche |
— |
1 |
| #390 |
Matthew R. Pickett |
Union Carbide |
1 |
| #390 |
Maben YING |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Ray Lotfi |
Certainteed |
1 |
| #390 |
Judith E. Miller |
Merck |
1 |
| #390 |
Sara Thrall |
Ab Sciex |
1 |
| #390 |
Mariela Colon |
Glaxosmithkline |
1 |
| #390 |
Mala Kiran Talekar |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Douglas Dennis Richardson, II |
Merck |
1 |
| #390 |
Kaushal Kishore |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Kenneth William Hance |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Yan Y. DEGENHARDT |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Gopinath Ganji |
Glaxosmithkline |
1 |
| #390 |
Kimberly N. Smitheman |
Glaxosmithkline |
1 |
| #390 |
Elizabeth Marks |
Globus Medical |
1 |
| #390 |
Ananth Dandibhotla |
Unknown |
1 |
| #390 |
Michael T. MCCABE |
Glaxosmithkline |
1 |
| #390 |
Gerald Kuehl |
Animas |
1 |
| #390 |
Laura M. SEESTALLER-WEHR |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
William E. Fieles |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
James Tunstead |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Paul Schiele |
— |
1 |
| #390 |
Vivek Tomer |
Dow Global Technologies |
1 |
| #390 |
Yunfeng Lan |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Ramanan Thiagarajah |
Experian Health |
1 |
| #390 |
Mukesh Mahajan |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
George Grevera |
University of Pennsylvania |
1 |
| #390 |
James H. Fife |
Educational Testing Service |
1 |
| #390 |
Gina M Andaloro |
— |
1 |
| #390 |
Ruth Tal-Singer |
Glaxosmithkline Biologicals Sa |
1 |
| #390 |
Jagannadha R. Jakilinki |
Verizon |
1 |
| #390 |
Gregg Barcan |
Glaxosmithkline Intellectual Property (No. 4) Limited |
1 |
| #390 |
Janet Drobits Windisch |
Conopeo |
1 |
| #390 |
Anthony F DiCastelnuovo |
— |
1 |
| #390 |
Christopher W. Morgan |
Glaxosmithkline Intellectual Property (No. 4) Limited |
1 |
| #390 |
Michael NAPIER |
— |
1 |
| #390 |
Hongyi Lu |
Glaxosmithkline Intellectual Property (No. 4) Limited |
1 |
| #390 |
Christopher B. HOPSON |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
María Lourdes Rueda Benede |
Cancer Research Technology Limited |
1 |
| #390 |
Andy FEDORIW |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Sarah Gerhart |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Jacob Rubin |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Ping Zhang |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Gopalam Somasekhar |
Ocugen |
1 |
| #390 |
Christopher M. Smirga |
Synopsys |
1 |
| #390 |
Niyant Shah |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Ryan G. Kruger |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Helai MOHAMMAD |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Jenny Laraio |
Glaxosmithkline Intellectual Property Development Limited |
1 |